AILMENTS

USA flag icon with a marijuana leaf

Although cannabis remains illegal on the federal level in the United States, some individual states have legalized cannabis for valid medical purposes (and two states, Washington and Colorado, have legalized cannabis both medically and recreationally).

Here’s a list of which states authorize medical marijuana for valid, qualified patients. Each entry includes a link to the state’s qualifying conditions, as well as a rundown of which medical conditions and symptoms must be verified by a physician in order to get authorized as a valid medical marijuana patient. Please note that some states allow physicians to approve other medical conditions not listed on a case-by-case basis, so check with your doctor.

Listed below are varying pages of states with Cannabinoid Acts and Forms:

 

                         Click on any of the following States to Link to Specific Information

        Alaska                                         Arizona                                    California                        Colorado

   Connecticut                       DC – District of Columbia             Delaware                            Hawaii

       Illinois                                          Maine                                      Maryland                     Massachusetts

     Michigan                                   Minnesota                                  Montana                            Nevada

New Hampshire                          New Jersey                              New Mexico                      New York

     Oregon                                     Rhode Island                              Vermont                        Washington

________________________________________________________________

Alaska

Qualifying conditions include:

Cancer

Glaucoma

HIV/AIDS

Cachexia (wasting syndrome)

Pain

Nausea

Seizures

Muscle spasms

Multiple Sclerosis

For a complete list of qualifying conditions and guidelines, please refer to Alaska’s application for medical marijuana registry.

 

Arizona

Qualifying conditions include:

Cancer

Glaucoma

HIV/AIDS

Cachexia (wasting syndrome)

Pain

Nausea

Seizures

Muscle spasms

Multiple sclerosis

PTSD

For a complete list of qualifying conditions and guidelines, please refer to the Arizona state legislature concerning medical marijuana.

 

California

Qualifying conditions include:

Cancer

Anorexia

AIDS

Chronic pain

Cachexia

Persistent muscle spasms, including those associated with Multiple Sclerosis

Seizures, including, but not limited to, those associated with epilepsy

Severe nausea

Glaucoma

Arthritis

Migraines

Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities, as defined by the Americans with Disabilities Act of 1990; or, if not alleviated, may cause serious harm to the patient’s safety or physical or mental health.

For a complete list of qualifying conditions and guidelines, please refer to  California Proposition 215, with revised Senate Bill 420.

 

Colorado

Although Colorado has implemented a legal recreational cannabis market, it still operates medical marijuana dispensaries for valid patients. Colorado MMJ patients still pay standard sales tax on cannabis but are exempt from the high excise taxes and additional state taxes collected from recreational cannabis sales.

Qualifying conditions include:

Cancer

Glaucoma

HIV/AIDS

Cachexia (wasting syndrome)

Persistent muscle spasms

Seizures

Severe nausea

Severe pain

For a complete list of qualifying conditions and guidelines, please refer to Colorado’s Debilitating Conditions for Medical Marijuana Use.

 

Connecticut

Qualifying conditions include:

Cancer

Cancer

Glaucoma

HIV/AIDS

Parkinson’s disease

Multiple sclerosis

Damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity

Epilepsy

Cachexia (wasting syndrome)

Wasting syndrome

Crohn’s disease

Post-traumatic stress disorder (PTSD)

For a complete list of qualifying conditions and guidelines, please refer to Connecticut’s medical marijuana qualification requirements.

 

Delaware

Qualifying conditions include:

Cancer

HIV/AIDS

Hepatitis C

Lou Gehrig’s disease (Amyotrophic lateral sclerosis, or ALS)

Alzheimer’s

Post-traumatic stress disorder (PTSD)

Cachexia (wasting syndrome)

Intractable nausea

Seizures

Muscle spasms

Multiple sclerosis

For a complete list of qualifying conditions and guidelines, please refer to medical marijuana program guidelines.

 

District of Columbia

Qualifying conditions include:

HIV/AIDS

Cancer

Glaucoma

Muscle spasms

Multiple sclerosis

Lou Gehrig’s Disease (ALS)

Cachexia (wasting syndrome)

decompensated cirrhosis

Alzheimer’s Disease

Seizure disorders

For a complete list of qualifying conditions and guidelines, please refer to the District of Columbia’s Medical Marijuana Program Patient FAQ.

 

Florida

Florida only allows for the use of cannabis extracts that are low in THC and high in CBD, as well as allowing a legal defense for the use of low THC cannabis for medicinal purposes.

Qualifying conditions include:

Severe, debilitating epileptic conditions

For a complete list of qualifying conditions and guidelines, please refer to the Florida Senate’s Bill Analysis.

 

Georgia

Georgia only allows for the use of low THC oil (less than 5% THC by weight).

Qualifying conditions include:

Cancer

Amyotrophic lateral sclerosis (ALS)

Seizure disorders related to diagnosis of epilepsy or trauma-related head injuries

Multiple sclerosis

Crohn’s diseas

Mitochondrial disease

Parkinson’s disease

Sickle cell diease

For a complete list of qualifying conditions and guidelines, please refer to House Bill 1 (Haleigh’s Hope Act).

 

Hawaii

Qualifying conditions include:

Cancer

Glaucoma

HIV/AIDS

Cachexia (wasting syndrome)

Pain

Nausea

Seizures

Muscle spasms

Multiple sclerosis

For a complete list of qualifying conditions and guidelines, please refer to Hawaii Senate Bill 862.

 

Illinois

Qualifying conditions include:

Acquired Immunodeficiency Syndrome (AIDS)

Anorexia nervosa*

Alzheimer’s disease

Amyotrophic Lateral Sclerosis (ALS)

Arnold-Chiari malformation and Syringomelia

Cachexia/wasting syndrome

Cancer

Causalgia

Chronic Inflammatory Demyelinating Polyneuropathy

Chronic Post-Operative Pain*

Crohn’s disease

CRPS (Complex Regional Pain Syndrome Type II)

Dystonia

Ehlers-Danlos Syndrome*

Fibromyalgia (severe)

Fibrous dysplasia

Glaucoma

Hepatitis C

Human Immunodeficiency Virus (HIV)

Hydrocephalus

Interstitial Cystitis

Irritiable Bowel Syndrome*

Lupus

Migraines*

Multiple Sclerosis

Muscular Dystrophy

Myasthenia Gravis

Myoclonus

Nail-patella syndrome

Neuro-Behcet’s Autoimmune Disease*

Neurofibromatosis

Neuropathy (peripheral and diabetic)*

Osteoarthritis*

Parkinson’s disease

Polycystic kidney disease*

Post-concussion syndrome

Post-traumatic stress disorder (PSTD)*

RSD (Complex Regional Pain Syndromes Type I)

Residual limb pain

Rheumatoid arthritis (RA)

Seizures

Sjogren’s syndrome

Spinal cord diesase (including, but not limited to arachnoiditis, Tarlov cysts, hydromyelia & syringomelia)

Spinal cord injury

Spinocerebellar Ataxia (SCA)

Superior Canal Dehiscence Syndrome*

Tourette’s syndrome

Traumatic brain injury (TBI)

*New conditions recommended by the Illinois Medical Cannabis Advisory Board.

For a complete list of qualifying conditions and guidelines, please refer to

the Illinois Medical Cannabis Pilot Program’s FAQ.

Iowa

Iowa allows for the use of high-CBD cannbis extracts with less than .3% THC.

Qualifying conditions include:

Intractable epilepsy

For a complete list of guidelines, please refer to Iowa Medical Cannabidiol Act Quick Facts.

 

Kentucky

Kentucky allows for the use of low-THC cannabis or industrial hemp-derived CBD oil.

Only those who are participating in a clinical trial or expanded access program are legally allowed to possess CBD oil

For more information on accessing CBD in Kentucky, please refer to Senate Bill 124.

 

Maine

Qualifying conditions include:

Chronic pain (which has not responded to conventional therapy for more than six months)

Post-traumatic stress disorder (PTSD)

Lou Gehrig’s disease (Amyotrophic lateral sclerosis, or ALS)

Alzheimer’s disease

Cachexia (wasting syndrome)

Cancer

Crohn’s disease

Glaucoma

Hepatitis C (active form)

HIV

Inflammatory bowel disease (IBS)

Seizure disorders

Severe muscle spasms (including multiple sclerosis and other diseases causing severe and persistent muscle spasms)

Severe nausea

For a complete list of qualifying conditions and guidelines, please refer to Maine’s medical use of marijuana guidelines.

Maryland

Qualifying conditions include:

Cachexia (wasting syndrome)

Severe, debilitating, or chronic pain

Severe nausea

Seizures, including those characteristic of epilepsy

Severe and persistent muscle spasms

Multiple sclerosis

Crohn’s disease

Alzheimer’s disease

Cancer

Glaucoma

HIV/AIDS

Hepatitis C

For a complete list of qualifying conditions and guidelines, please refer to Maryland Senate Bill 757.

 

Massachusetts

Qualifying conditions include:

Cancer

Glaucoma

AIDS

Hepatitis C

Lou Gehrig’s disease (Amyotrophic lateral sclerosis, or ALS)

Crohn’s disease

Parkinson’s disease

Multiple sclerosis

For a complete list of qualifying conditions and guidelines, please refer to the Massachusetts medical use of marijuana overview.

Michigan

Qualifying conditions include:

Cancer

Glaucoma

HIV/AIDS

Hepatitis C

Lou Gehrig’s disease (Amyotrophic lateral sclerosis, or ALS)

Alzheimer’s

Nail-patella syndrome

Cachexia (wasting disease)

Severe and chronic pain

Severe nausea

Seizures

Epilepsy

Muscle spasms

Multiple sclerosis

For a complete list of qualifying conditions and guidelines, please refer to the Michigan Medical Marihuana Registry Program FAQ.

Mississippi

Mississippi allows access to CBD oil only.  Qualifying conditions include:

Debilitating epileptic seizure disorders

Must receive medical recommendation by physician from University of Mississippi Medical Center to participate in clinical trial.  For more information, please refer to House Bill 1231 or Harper Grace’s Law.

 

Montana

Qualifying conditions include:

Cancer

Glaucoma

HIV/AIDS

Cachexia (wasting syndrome)

Chronic pain

Intractable nausea or vomiting

Epilepsy or an intractable seizure disorder

Multiple sclerosis

Crohn’s disease

Painful peripheral neuropathy

A central nervous system disorder resulting in chronic, painful spasticity or muscle spasms

For a complete list of qualifying conditions and guidelines, please refer to Montana Code Annotated 2013.

 

Nevada

Qualifying conditions include:

AIDS

Cancer

Glaucoma

Condition or treatment for a medical condition that produces cachexia (general physical wasting and malnutrition)

Persistent muscle spasms (including multiple sclerosis)

Seizures (including epilepsy)

Severe nausea

Severe pain

For a complete list of qualifying conditions and guidelines, please refer to the Nevada Medical Marijuana Program.

 

New Hampshire

Qualifying conditions include:

A chronic or terminal disease

Cachexia (wasting syndrome)

Severe pain

Severe nausea/vomiting

Seizures

Severe, persistent muscle spasms

For a complete list of qualifying conditions and guidelines, please refer to New Hampshire House Bill 573.

 

New Jersey

Qualifying conditions include:

Lou Gehrig’s disease (Amyotrophic lateral sclerosis, or ALS)

Multiple sclerosis

Terminal cancer

Muscular dystrophy

Inflammatory bowel disease (IBS)

Crohn’s disease

Terminal illness if the physician has determined a prognosis of less than 12 months of life

Seizure disorder, including epilepsy

Intractable skeletal muscular spasticity

Glaucoma

HIV/AIDS

Cancer

For a complete list of qualifying conditions and guidelines, please refer to the New Jersey Medicinal Marijuana Program.

 

New Mexico

Qualifying conditions include:

Severe chronic pain

Painful peripheral neuropathy

Intractable nausea/vomiting

Severe anorexia

Cachexia (wasting syndrome)

Hepatitis C infection currently receiving antiviral treatment

Crohn’s disease

Post-traumatic stress disorder (PTSD)

Lou Gehrig’s disease (Amyotrophic lateral sclerosis, or ALS)

Cancer

Glaucoma

Multiple sclerosis

Damage to the nervous tissue of the spinal cord with intractable spasticity

Epilepsy

HIV/AIDS

Inflammatory autoimmune-mediated arthritis

Hospice patients

For a complete list of qualifying conditions and guidelines, please refer to the New Mexico Medical Cannabis Program FAQ.

 

New York

Qualifying conditions include:

Cancer

Epilepsy

HIV/AIDS

Huntington’s Disease

Inflammatory Bowel Disease (IBS)

Lou Gehrig’s Disease (ALS)

Parkinson’s Disease

Multiple Sclerosis (MS)

Neuropathies

Spinal cord damage

For a complete list of qualifying conditions and guidelines, please refer to the New York State Medical Marijuana Program FAQ.

 

Oregon

Qualifying conditions include:

Cancer

Glaucoma

Alzheimer’s

HIV/AIDS

Cachexia (wasting syndrome)

Severe pain

Severe nausea

Seizures, including but not limited to seizures caused by epilepsy

Persistent muscle spasms

Multiple sclerosis

For a complete list of qualifying conditions and guidelines, please refer to the Oregon Medical Marijuana Act.

 

Rhode Island

Qualifying conditions include:

Cancer

Glaucoma

HIV/AIDS

Hepatitis C

Cachexia (wasting syndrome)

Chronic pain

Severe nausea

Seizures, including but not limited to those characteristic of epilepsy

Severe and persistent muscle spasms

Multiple sclerosis

Crohn’s disease

Alzheimer’s

For a complete list of qualifying conditions and guidelines, please refer to Rhode Island’s medical marijuana approved qualifying debilitating medical conditions.

 

South Carolina

South Carolina allows for CBD oil only.  Qualifing conditions include:

Certain forms of epilepsy as part of a state-run clinical trial

For more infomation, please refer to the Medical Cannabis Therapeutic Treatment Research Act.

 

Vermont

Qualifying conditions include:

Cancer

AIDS/HIV

Multiple sclerosis

Cachexia (wasting syndrome)

Severe pain

Nausea

Seizures

For a complete list of qualifying conditions and guidelines, please refer to the Vermont patient marijuana registry FAQ.

 

Washington

Although Washington voters have passed Initiative 502, which will result in a legal recreational cannabis market, it will not debut until late spring/early summer 2014. Until that time, cannabis can still only be acquired by valid medical marijuana patients.

Qualifying conditions include:

Cancer

HIV/AIDS

Multiple sclerosis

Epilepsy or other seizure disorder

Spasticity disorders

Intractable pain

Glaucoma

Crohn’s disease

Hepatitis C

Diseases, including anorexia, which result in nausea, vomiting, wasting, appetite loss, cramping, seizures, muscle spasms, or spasticity

For a complete list of qualifying conditions and guidelines, please refer to the  Washington state legislature regarding medical cannabis.